GDF15

 Growth/differentiation factor 15 (GDF15) was first identified as Macrophage inhibitory cytokine-1 or MIC-1.[5]

GDF15
Identifiers
AliasesGDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB, growth differentiation factor 15, TGF-PL
External IDsOMIM605312 MGI1346047 HomoloGene3576 GeneCardsGDF15
Gene location (Human)
Chromosome 19 (human)
Chr.Chromosome 19 (human)[1]
Chromosome 19 (human)
Genomic location for GDF15
Genomic location for GDF15
Band19p13.11Start18,374,731 bp[1]
End18,389,176 bp[1]
RNA expression pattern
PBB GE GDF15 221577 x at fs.png
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_004864

NM_011819
NM_001330687

RefSeq (protein)

NP_004855

NP_001317616
NP_035949

Location (UCSC)Chr 19: 18.37 – 18.39 MbChr 8: 70.63 – 70.63 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

It is a protein belonging to the transforming growth factor beta superfamily. Under normal conditions, GDF-15 is expressed in low concentrations in most organs and upregulated because of injury of organs such as such as liverkidneyheart and lung.[6][7][8]

The function of GDF-15 is not fully cleared but it seems to have a role in regulating inflammatory pathways and to be involved in regulating apoptosis, cell repair and cell growth, which are biological processes observed in cardiovascular and neoplastic disorders.[6][9][10] GDF-15 has shown to be a strong prognostic protein in patients with different diseases such as heart diseases and cancer.[11]

Metformin was shown to cause increased levels of GDF-15. This increase mediates the effect of body weight loss by metformin.[12]

A monoclonal antibody (mAB1) that neutralizes circulating GDF-15 is being tested in mice and non-human primates as a potential treatment for cancer-related cachexia.[13]

This article uses material from the Wikipedia article
 Metasyntactic variable, which is released under the 
Creative Commons
Attribution-ShareAlike 3.0 Unported License
.